Corporate Finance

Conning's latest report reveals a dramatic shift in U.S. state economies. While the outlook is stable, new metrics on cost and climate are separating the winners from the losers.

Volition America's Jeep giveaway for military heroes is more than a contest; it's a masterclass in modern brand-building and corporate philanthropy.

An Israeli-American tech firm just put AI eyes on a US Black Hawk, pioneering a new era of visual predictive maintenance that could transform aviation safety.

A strategic investment in AxisCare signals a major shift as private equity fuels AI's move from the data center to the living room, reshaping elder care.

Jianzhi Education secures $5M in a deal that halves its stock price, revealing a clash between urgent capital needs and a long-term vision for AI innovation.

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

JFrog's inclusion in the Russell 3000 isn't just a corporate win; it's a signal of the market's new respect for the software supply chain's vital role.

Browser innovator Shift renews its $25K Impact Grant, fueling sustainable startups as the tech industry grapples with its growing environmental footprint.

After a turbulent past, Movement is betting its future on a new model for emerging markets, marrying licensed payment rails with blockchain. Is it a true revolution?

Ahead of its token launch, nGRND has drawn 855k gamers with a novel promise: rewards backed by preserved, unmined gold. Is this the future of Web3?

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

A California small business beat 11 rivals for a landmark FBI armor contract. The Nguyen Report dissects the strategy and tech setting a new industry standard.

QuickLogic's inclusion in the Russell 2000 is a major milestone, but a deeper look reveals a story of high-stakes tech, steep valuation, and intense competition.

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

NXG NextGen Infrastructure Fund boosts its dividend by 11.1%, but it's all 'return of capital'. We deconstruct what this means for income investors.

A new study reveals molecular and AI-imaging tests provide distinct clues for Parkinson's, championing a dual-biomarker approach for earlier, more accurate diagnosis.

After a period of explosive growth and a landmark IPO, StandardAero's CEO is retiring. His successor, a GE veteran, inherits a market leader facing new challenges.

The Buckle's latest dividend isn't just a shareholder payout; it's a signal of strategic resilience in a tough retail market. Here's the deeper story.

A new manufacturing deal sees Bluejay Diagnostics bet on U.S. resilience. It's a strategic retreat from global risk for a firm facing a long regulatory road.

Vision Marine's new, denser batteries from Octillion aren't just a tech upgrade; they're a strategic move to outpace rivals in the booming electric boat market.